Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | RELA | Q04206 | 1/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | PHGDH | O43175 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26255406 | 0.84 | KMT2A (0.38) | KMT2AMEN1HTTRELATAAR1 | |
| SCHEMBL25175053 | 0.84 | KMT2A (0.38) | KMT2AMEN1HTTRELATAAR1 | |
| SCHEMBL26255290 | 0.82 | KMT2A (0.37) | KMT2AMEN1HTTRELATAAR1 | |
| SCHEMBL25174581 | 0.82 | KMT2A (0.37) | KMT2AMEN1HTTRELATAAR1 | |
| SCHEMBL26255382 | 0.82 | KMT2A (0.37) | KMT2AMEN1HTTRELATAAR1 | |
| SCHEMBL22344771 | 0.78 | ALDH1A1 (0.36) | KMT2AMEN1HTTTAAR1ALDH1A1 | |
| SCHEMBL3122245 | 0.76 | KMT2A (0.48) | KMT2AMEN1HTTRELAALDH1A1 | |
| SCHEMBL25168581 | 0.74 | MEN1 (0.34) | KMT2AMEN1HTTTAAR1ALDH1A1 | |
| SCHEMBL26255544 | 0.74 | MEN1 (0.34) | KMT2AMEN1HTTRELATAAR1 | |
| SCHEMBL26255431 | 0.74 | MEN1 (0.39) | KMT2AMEN1HTTRELATAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230287562-A1 | COMPOSITIONS ND METHODS USING SAME FOR GERMANIUM SEED LAYER | VERSUM MATERIALS US, LLC | 2023-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230287562-A1 | COMPOSITIONS ND METHODS USING SAME FOR GERMANIUM SEED LAYER | GMNN, AGL, GYS2 | KMT2A 3049/4885MEN1 2450/4885HTT 2515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.